Intellectual Property India Publishes Patent Application for 'Cell Therapy' Filed by The Walter And Eliza Hall Institute Of Medical Research

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517034909 A) filed by The Walter And Eliza Hall Institute Of Medical Research, Melbourne, Australia, on April 9, for 'cell therapy.'

Inventor(s) include Nutt Stephen; Zhang Shengbo; and Chopin Michael.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides for chimeric antigen receptor constructs capable of being expressed in dendritic cells (DCs) and DCs modified to express one or more chimeric antigen receptors (CARs) as well as compositions comprising these modified DCs and methods of stimulating an adaptive immune response in a subject. The intracellular domain of the CAR comprises a toll interleukin receptor (TIR) intracellular signalling domain and a costimulating domain selected from CD3 signalling domain CD28 signalling domain and a combined CD28 and CD3 signalling domain."

The patent application was internationally filed on Oct. 17, 2023, under International application No.PCT/AU2023/051023.

Disclaimer: Curated by HT Syndication.